Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-112576
Filing Date
2025-11-14
Accepted
2025-11-14 16:20:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5856
  Complete submission text file 0001104659-25-112576.txt   7673
Mailing Address 130 MAIN ST 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST 2ND FLOOR NEW CANAAN CT 06840 203-909-6430
Nantahala Capital Partners Limited Partnership (Filed by) CIK: 0001502725 (see all company filings)

EIN.: 201220305 | State of Incorp.: MA | Fiscal Year End: 1210
Type: SCHEDULE 13G/A

Mailing Address 322 W 57TH ST. #33B NEW YORK NY 10019
Business Address 322 W 57TH ST. #33B NEW YORK NY 10019 972-4-770-6377
DarioHealth Corp. (Subject) CIK: 0001533998 (see all company filings)

EIN.: 452973162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88306 | Film No.: 251486696
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)